A subdermal contraceptive implant stands for the hormonal birth control method. The progestin hormone is released into the body by the implant to prevent pregnancy. Progestin prevents pregnancy by preventing the release of eggs from the ovaries. It thickens cervical mucus as well as preventing sperm from entering the uterus. Subdermal contraceptive implants use rods or polymer capsules to inject steroid progestin under the skin. It offers several benefits, including long-term contraception that does not necessitate consumer attention.
Without using estrogen, subdermal contraceptive implants are extremely successful at a low dose. Long-term contraceptive intervention without needing the provider’s or user’s attention and fertility is easily reversible after the implant is removed are all advantages of subdermal contraceptive implants. For one to five years, a subdermal contraceptive implant helps to prevent pregnancy. The duration of protection is determined by the type of progestin used and the type of polymer used.
Key Dynamics of Subdermal Contraceptive Implants Market
Increased adoption of various advanced contraceptive methods, rising knowledge about family planning and sexual health, and increased government initiatives are expected to drive the growth of the subdermal contraceptive implant market. The government is burdened by rising unwanted pregnancies and a proportional increase in the number of abortions. As a result, several governments have launched numerous initiatives to expand and increase access to various contraceptive methods.
Some countries and governments have recognized the need to reduce the number of unintended pregnancies and have launched a slew of programs to educate people and discourage unwanted pregnancies and abortions. The freedom to obtain and use contraception is protected under the United States Constitution’s constitutional right to privacy. As a result, government programs encourage the use of contraception to prevent unintended pregnancies.
North America Dominates the Subdermal Contraceptive Implants Market
North America is projected to grow rapidly, thanks to sophisticated healthcare infrastructure, a high rate of contraceptive drug uptake, and a growing number of government initiatives aimed at expanding the overall market. In both the United States and Canada, a significant portion of the female population is of reproductive age. As a result, a large portion of the population is at risk of premature pregnancy because their spouses do not use contraception properly and regularly.
The public is well-informed about these types of products and many hospitals have stepped in to help patients who have been harmed by their misuse. Furthermore, many companies focusing on setting up proper distribution channels to ensure the proper management of the demand and supply process, which drives the market and accounts for the largest share.
Leading Players Operating in the Subdermal Contraceptive Implants Market
The subdermal contraceptive implants market is highly fragmented as several players started investing heavily and looking to strengthen the foothold in the market. Companies such as Allergan plc, Shanghai Dahua Pharmaceutical Co., Ltd., Reckitt Benckiser Group plc, Karex Industries, Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., The Female Health Company, KESSEL medintim GmbH, and Mayer Laboratories hold a substantial market share in the global market.
Deep-dive Insights on Subdermal Contraceptive Implants Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/subdermal-contraceptive-implants-market/request-for-sample